How should I manage a 78‑year‑old man with type 2 diabetes who is on basal insulin glargine (Lantus) 10 U daily and has glucose readings ranging from 171 to 332 mg/dL?

Immediate Insulin Intensification Required for Severe Uncontrolled Diabetes

This 78-year-old man with blood glucose ranging 171–332 mg/dL on only 10 units of Lantus daily requires immediate and aggressive insulin dose escalation using a systematic titration protocol, with the goal of achieving fasting glucose 80–130 mg/dL within 2–3 weeks. 1

---

Immediate Basal Insulin Titration

Increase Lantus by 4 units every 3 days until fasting glucose consistently reaches 80–130 mg/dL, because current glucose values ≥171 mg/dL indicate profound under-dosing. 1, 2

Specific Titration Algorithm:

• If fasting glucose ≥180 mg/dL (as seen with readings up to 332 mg/dL): increase by 4 units every 3 days 1, 2
• If fasting glucose 140–179 mg/dL: increase by 2 units every 3 days 1, 2
• Target fasting glucose: 80–130 mg/dL 1, 2
• If any glucose reading falls <70 mg/dL: immediately reduce dose by 10–20% 1

Expected Dose Requirements:

• A starting dose of 10 units is profoundly inadequate for most adults; typical weight-based dosing for insulin-naïve patients is 0.1–0.2 units/kg/day 1, 2
• For a 78-year-old man (estimated 70–80 kg), this translates to an initial target of 14–16 units, with further escalation likely needed 1, 2
• Many patients with glucose in the 200–300 mg/dL range require 0.3–0.5 units/kg/day (21–40 units) to achieve control 1

---

Critical Threshold: When to Add Prandial Insulin

Stop escalating basal insulin when the dose approaches 0.5 units/kg/day (approximately 35–40 units for this patient) without achieving glycemic targets. At this threshold, add prandial insulin rather than continuing basal escalation to avoid "over-basalization." 1, 2

Signs of Over-Basalization:

• Basal dose >0.5 units/kg/day without meeting targets 1
• Bedtime-to-morning glucose differential ≥50 mg/dL 1
• Any hypoglycemia episodes despite overall hyperglycemia 1
• High glucose variability throughout the day 1

Initiating Prandial Insulin (When Needed):

• Start with 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before the largest meal 1, 3
• Alternative: use 10% of current basal dose as the starting prandial dose 1, 3
• Administer 0–15 minutes before meals for optimal post-prandial control 1, 3
• Titrate each meal dose by 1–2 units every 3 days based on 2-hour post-prandial glucose 1, 3

---

Essential Foundation Therapy: Metformin

Continue or optimize metformin to at least 1000 mg twice daily (2000 mg total) unless contraindicated, as this combination reduces total insulin requirements by 20–30% and provides superior glycemic control compared to insulin alone. 1, 2

• Metformin should never be discontinued when intensifying insulin therapy unless specific contraindications exist (renal impairment, acute illness, tissue hypoxia) 1
• Maximum effective dose is up to 2500 mg/day 1

---

Monitoring Requirements During Titration

Daily Glucose Checks:

• Fasting glucose every morning to guide basal insulin adjustments 1, 2
• If adding prandial insulin: check pre-meal glucose before each meal and 2-hour post-prandial glucose after meals 1, 3
• Minimum 4 checks daily during intensive titration phase 1

Follow-Up Schedule:

• Reassess every 3 days during active titration to adjust insulin dose 1, 2
• HbA1c every 3 months until stable control achieved 1
• Urgent endocrinology referral if HbA1c >9% or glucose remains uncontrolled after 3–6 months 1, 2

---

Expected Clinical Outcomes

With proper basal insulin titration:

• Approximately 68% of patients achieve mean glucose <140 mg/dL with scheduled basal-bolus therapy, versus only 38% with inadequate dosing 1
• HbA1c reduction of 1.5–2.0% is achievable with basal insulin optimization alone 1
• Additional 2–3% HbA1c reduction possible if prandial insulin becomes necessary 1
• Properly implemented regimens do not increase hypoglycemia risk compared to under-dosed insulin 1

---

Critical Pitfalls to Avoid

• Do not delay insulin dose escalation when glucose consistently exceeds 180 mg/dL; prolonged hyperglycemia increases complication risk 1, 2
• Do not continue escalating basal insulin beyond 0.5–1.0 units/kg/day without addressing post-prandial hyperglycemia; this leads to over-basalization with increased hypoglycemia risk 1, 2
• Do not discontinue metformin when intensifying insulin unless contraindicated; this leads to higher insulin requirements and worse outcomes 1, 2
• Never use sliding-scale insulin as monotherapy; correction doses must supplement—not replace—scheduled basal insulin 1

---

Patient Education Essentials

• Hypoglycemia recognition and treatment: treat glucose <70 mg/dL with 15 g fast-acting carbohydrate, recheck in 15 minutes 1
• Proper insulin injection technique and site rotation to prevent lipohypertrophy 1, 2
• Self-titration algorithm: empower patient to adjust insulin dose based on fasting glucose readings 1, 2, 4
• Sick-day management: continue insulin even when not eating, check glucose every 4 hours, maintain hydration 1, 2

---

Alternative: GLP-1 Receptor Agonist Consideration

If basal insulin exceeds 0.5 units/kg/day without achieving targets, consider adding a GLP-1 receptor agonist (e.g., semaglutide) instead of prandial insulin, offering comparable post-prandial control with less hypoglycemia and weight loss rather than weight gain. 1, 5